Integra Devices Recognized as the Industry Leader by Frost & Sullivan for Innovations in Micro-Sensors

2018 Best Practices Award

UCI spin-out Integra Devices has been awarded Frost & Sullivan’s “2018 Innovation Award” for the 3D micro-sensors and devices industry in North America. With their proprietary and novel manufacturing paradigm, AMALGATM, Integra has pioneered breakthroughs in micro-device development by enabling and building products that before were not yet possible. As the world’s leading market research and consulting organizations, Frost & Sullivan identify and assess key emerging and disruptive technologies through various industries. After thorough investigation of the market, Frost & Sullivan recognized Integra for innovation and best practice.

AMALGATM drives key advancements in the micro sensors and micro- devices industries by enabling more effective and efficient manufacturing of a wider range of highly innovative and significant devices at the MEMS scale. micro manufacturing technology enables the fabrication of more robust, integrated yet low-cost 3D products that cannot be effectively built using standard MEMS or thin-film semiconductor technologies. ​

“Integra exceeds competitors in manufacturing innovative micro-devices that significantly impact the sensors industry”, Frost & Sullivan highlights.​

To learn more about Integra’s unique capabilities and what Integra can do for you, Contact Sourabh Dhillon today at 

More about Integra Devices:

Integra Devices is a next-generation industrial component company that provides a new breed of micro-devices for high value markets such as telecom, aerospace, manufacturing, and medicine.

Source: Integra Devices


Categories: Manufacturing, Electrical and Electronics

Tags: actuators, aerospace and defense, biomedical, biosensors, biotechnology, manufacturing, MEMS, micro-devices, relays, rf devices, sensors, telecommunications

About Xidas

View Website

Xidas leverages a groundbreaking new paradigm to build
micro-devices, created from over 15 years of research and over $20M in funding at UC Irvine.